As CEO of Lifechek Drug, Bruce Gingrich leads the largest independently owned drugstore chain in the United States. To ensure continued success, Bruce Gingrich enhances his expertise through active involvement with the National Association of Chain Drug Stores (NACDS).
NACDS heads to Fort Lauderdale, Florida, in February for its 2016 Regional Chain Conference. Commencing on February 7, the event spans three days and includes speakers Deborah Kelly, partner and deputy general counsel of Dickstein Shapiro, and Doug Long, industry relations vice president of IMS Health. Attendees will learn about pharmaceutical trends, marketing strategies, and relationship development. Select sessions provide continuing education credits that must be claimed within 60 days of the program.
The conference is business casual. New participants will benefit from attending the First-Timer’s Orientation, and all guests should make time to join the Super Bowl party on Sunday evening, which serves as an icebreaker and networking opportunity.
As the CEO and owner of Lifechek Drug, Bruce Gingrich participates in several organizations that advocate for the drug store industry. The National Association of Chain Drug Stores (NACDS) not only provides networking opportunities and increased visibility for companies owned by people like Bruce Gingrich, but advocates on their behalf to legislative organizations as well.
NACDS-PAC, the organization’s political action committee, helps candidates who intend to advocate on behalf of pharmacies and patients seek election. By allowing large numbers of members and other supportive individuals to pool their contributions, NACDS-PAC allows for more effective and targeted political giving than individual donations could possibly achieve. NACDS also operates a grassroots advocacy program, RxIMPACT Grassroots, for pharmacists and other members of the pharmacy field; the program provides information on how to contact lawmakers on key pharmacy issues. Members can also go to the advocacy section of the NACDS website to learn more about current policy initiatives and how they affect drug stores and pharmacy professionals.